Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.
暂无分享,去创建一个
W. M. van der Flier | Y. Pijnenburg | H. Berkhof | M. Blankenstein | R. Veerhuis | N. Verwey | H. Twaalfhoven | M. Kester | Philip Scheltens And